SIMPLIFY POST-APPROVAL PATIENT DATA COLLECTION
Enhance post-approval data collection through engaging patient data capture programs.
Gain real-time access to high quality patient data through our cost-effective, scalable solution for interventional studies.
Minimize patient burden and integrate participation in observational studies into everyday life with a bring your own device (BYOD) approach.
Support high-quality data collection in a heterogenous real-world setting. ERT’s Post-Approval Platform enables global scalability with local adaptation, whilst maintaining integrity of trial.
REAP THE BENEFITS OF ERTS PROPRIETRY POST-APPROVAL PLATFORM
Have confidence in the knowledge that ERT has over 50 years of experience in the clinical research industry.
FLEXIBLE PROGRAM DESIGN
Ensure your individual study requirements are met with our modular approach. Position your program for success with ERT’s Post-Approval Platform and benefit from:
- Assessments and questionnaires
- Medical and consumer device integration
- Reminders and alerts
- Educational and motivational messaging
- Visit management
- Enhanced support through patient communities
REDUCE PATIENT BURDEN
Patient burden is often seen as a barrier to post-approval programs. With ERT’s BYOD approach you can support a better patient experience and long-term participation in post-approval programs through mobile data collection that integrates into everyday life.
CAPTURE HIGH-QUALITY REAL-WORLD DATA
Get confidence in the quality of your patient generated real-world data (RWD) with ERT’s Post-Approval Platform.
DRIVE BETTER INFORMED HEALTHCARE DECISIONS
Patient generated RWD is playing an increasingly important role in informing key healthcare decisions. Despite this, pharmaceutical companies have been slow to adopt patient-focused RWD programs, due in part to the challenges associated with capturing patient generated RWD.
Find out how ERT’s Post-Approval platform can reduce the burden of running Real-World Data programs.
UNLOCK THE PATIENT VOICE
RWD programs are enabling sponsors to gain important real-life insights into the value of new treatments and medications through the patient voice.
Capture high-quality data, reduce the patient burden and support healthcare decision making with ERT’s Post-Approval Platform.
MINIMIZE SPONSOR AND PATIENT BURDEN
Capturing patient-generated RWD is often perceived to be challenging by pharmaceutical companies. Overcome these challenges by adopting a digital solution which can:
- Reduce patient and sponsor burden
- Enhance data quality
- Support data capture across different types of post-approval programs
Register for our on-demand webinar ‘How Digital Technology Can Facilitate Effective Patient Data Capture in Real-World Data Programs’ to learn more.
TAKE A CLOSER LOOK
See how ERT’s solution can enhance post-approval and real-world evidence programs through engaging patient data capture solutions.
eBOOK: USING PATIENT GENERATED RWD TO DRIVE BETTER INFORMED HEALTHCARE DECISIONS
Explore the growing influence of the patient voice in real-world data programs.
ARTICLE: THE CHANGING FACE OF POST-MARKETING RESEARCH
Learn how technological advancements have impacted the rise of real-world evidence and humanistic patient reported outcomes.
INFOGRAPHIC: UNLOCK THE PATIENT VOICE
Discover how digital technology facilitates the capture of patient data in the real world.
REQUEST A MEETING TODAY
Our team of experts is always available to consult about our Post-Approval solutions. Submit your contact information and one of our experts will be in touch to schedule a meeting.